Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MAP2K1 G276W
i
Other names:
MAP2K1, MAPKK1, MEK1, PRKMK1, Mitogen-activated protein kinase kinase 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5604
Related biomarkers:
Expression
Mutation
CNA
Others
‹
MAP2K1 mutation (9)
MAP2K1 P124L (6)
MAP2K1 P124S (5)
MAP2K1 C121S (3)
MAP2K1 K57T (3)
MAP2K1 P124Q (3)
BRAF V600E + MAP2K1 I111S (2)
BRAF mutation + MEK1 P124L (2)
MAP2K1 F53Y (2)
MAP2K1 G128V (2)
MAP2K1 Q56P (2)
MAP2K1 V154I (2)
MAP2K1 V60E (2)
BRAF mutation + MAP2K1 mutation (1)
MAP2K1 C125S (1)
MAP2K1 E203K (1)
MAP2K1 F129L (1)
MAP2K1 F53L (1)
MAP2K1 G128D + KRAS mutation (1)
MAP2K1 K57E (1)
MAP2K1 K57N (1)
MAP2K1 P124 (1)
MAP2K1 S218D + MAP2K1 S222D (1)
MAP2K1 V211D (1)
MAP2K1 V211D + BRAF mutation (1)
RAS wild-type + BRAF wild-type + MAP2K1 N57K (1)
BRAF V600E + MAP2K1 P124S (0)
MAP2K1 G128D (0)
MAP2K1 I111S (0)
MAP2K1 S218D (0)
MAP2K1 S222D (0)
MAP2K1 mutation (9)
MAP2K1 P124L (6)
MAP2K1 P124S (5)
MAP2K1 C121S (3)
MAP2K1 K57T (3)
MAP2K1 P124Q (3)
BRAF V600E + MAP2K1 I111S (2)
BRAF mutation + MEK1 P124L (2)
MAP2K1 F53Y (2)
MAP2K1 G128V (2)
MAP2K1 Q56P (2)
MAP2K1 V154I (2)
MAP2K1 V60E (2)
BRAF mutation + MAP2K1 mutation (1)
MAP2K1 C125S (1)
MAP2K1 E203K (1)
MAP2K1 F129L (1)
MAP2K1 F53L (1)
MAP2K1 G128D + KRAS mutation (1)
MAP2K1 K57E (1)
MAP2K1 K57N (1)
MAP2K1 P124 (1)
MAP2K1 S218D + MAP2K1 S222D (1)
MAP2K1 V211D (1)
MAP2K1 V211D + BRAF mutation (1)
RAS wild-type + BRAF wild-type + MAP2K1 N57K (1)
BRAF V600E + MAP2K1 P124S (0)
MAP2K1 G128D (0)
MAP2K1 I111S (0)
MAP2K1 S218D (0)
MAP2K1 S222D (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MAP2K1 G276W
Melanoma
MAP2K1 G276W
Melanoma
vemurafenib
Sensitive: C3 – Early Trials
vemurafenib
Sensitive
:
C3
vemurafenib
Sensitive: C3 – Early Trials
vemurafenib
Sensitive
:
C3
MAP2K1 G276W
Melanoma
MAP2K1 G276W
Melanoma
dabrafenib
Sensitive: C3 – Early Trials
dabrafenib
Sensitive
:
C3
dabrafenib
Sensitive: C3 – Early Trials
dabrafenib
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login